US CDC vote to approve mRNA COVID-19 vaccine over J & J’s | Coronavirus Plague News

The US briefly suspended the use of the COVID jab in April, before it gained a profit beyond the usual, but fatal.

A group of foreign consultants at the U.S. Centers for Disease Control and Prevention (CDC) has voted to encourage Americans to opt for the COVID-19 vaccine approved for the Johnson & Johnson shooting, due to lack of it but sometimes fatalities. cases of blood clots.

The CDC’s Advisory Committee on Vaccination voted unanimously on Thursday to submit a proposal. Supervisor still needs to sign on the guide.

Fewer Americans have received the J&J vaccine than the other two vaccines on a larger scale. Of the more than 200 million people vaccinated in the United States, about 16 million received the J&J vaccine, according to CDC data.

Cases of thrombosis with thrombocytopenia syndrome (TTS), which include blood clots that are accompanied by decreased platelets, have already been reported in J&J vaccine recipients. The highest reports are for women under 50 years of age.

The CDC said the risk of such incidents is higher than previously thought, in both women and men. The agency has identified more than 50 cases of TTS in the US, with approximately 3.83 million cases of J&J submitted.

At least nine people have died in the US disaster, the CDC said.

The members of the group also said that the J&J vaccine does not work more effectively against COVID-19 than any other approved vaccine.

Speaking to the committee, the leading vaccine scientist J&J said the vaccine produces a strong and lasting immune response with a single shot.

“In areas where most people do not return to take second-line or supplementation, the stability of the Johnson & Johnson vaccine as a first step could make a huge difference in saving lives in the US and around the world,” J & J’s said. Dr. Penny Heaton said.

In the US, the shooting has been effective in reaching out to hard-to-reach people as well as places such as the homeless and shelters.

The J&J vaccine uses genetically modified adenovirus vaccines to boost the immune system in recipients, while another approved vaccine uses messenger RNA technology.

A single-dose J&J vaccine has been approved permission for emergency use in late February. In April, US authorities suspended vaccinations for 10 days to check for blood clots.

A CDC scientist said Thursday that the death toll from TTS has not dropped since standing in April.

J&J shares closed about 1 percent on the New York Stock Exchange. The company sells the vaccine at a non-profit price, which is why it did not make a lot of money.